The John Mcgivney Children Centre collaborates with the Prompt Institute on a large scale clinical trialDate Posted: Friday, October 7, 2016
JMCC is one of the three clinical sites involved in the PROMPT Institute’s randomized controlled trial (RCT) for children with Motor Speech Disorders. This clinical trial is the first of its kind and the largest to date, assessing the efficacy of PROMPT treatment for this population. PROMPT is an acronym for Prompts for Restructuring Oral Muscular Phonetic Targets. The technique is a tactile-kinesthetic approach that uses touch cues to a patient’s articulators (jaw, tongue, lips) to manually guide them through a targeted word, phrase or sentence.
Other clinical sites involved in this RCT study are The Speech and Stuttering Institute, Toronto and ErinoakKids, Greater Toronto Area.
Research team: Mileva Vuletic: Clinical Director of Speech Language Pathology, Michele Weerts, Speech Language Pathologiest, PROMPT Instructor, JMCC, Kris Bogdanovic: Speech Language Pathologist JMCC, Deborah Hayden, Research Director, The PROMPT Institute, Aravind Namasivayam Principal Investigator, The PROMPT Institute, Laurie Lessard: (absent): JMCC, Clinical Director
Click here for more news.